Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide

被引：2
|
作者：
Tiong, Ing S. [1 ,2 ,3 ]
Stevenson, William S. [4 ,5 ]
Wall, Meaghan [3 ,6 ]
Yap, Yan Zhuang [1 ]
Seymour, John F. [1 ,7 ,8 ]
Kenealy, Melita [3 ,9 ]
Blombery, Piers [1 ,7 ,8 ]
机构：
[1] Peter MacCallum Canc Ctr, 300 Grattan St, Melbourne, Vic 3000, Australia
[2] Alfred Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic, Australia
[4] Royal North Shore Hosp, St Leonards, NSW, Australia
[5] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia
[6] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia
[7] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Cabrini Hlth, Melbourne, Vic, Australia
来源：
EJHAEM | 2023年 / 4卷 / 04期
关键词：
RISK; DDX41;
D O I：
10.1002/jha2.767
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1212 / 1215
页数：4
相关论文
共 50 条
  • [31] Infections in Patients with Myelodysplastic Syndrome/Acute Myeloid Leukemia Treated with Azacitidine: Report from a Single Center
    Quinto, Angela Maria
    De March, Elena
    Castelli, Monica
    Piazza, Francesco
    Adami, Fausto
    Semenzato, Gianpietro
    Binotto, Gianni
    BLOOD, 2014, 124 (21)
  • [32] Myelodysplastic Syndrome with Excess Blasts and Secondary Acute Myeloid Leukemia: Same Disease with Different Blast Count
    Chen, Xueyan
    Othus, Megan
    Wood, Brent L.
    Walter, Roland B.
    Becker, Pamela S.
    Percival, Mary-Elizabeth M.
    Abkowitz, Janis L.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    BLOOD, 2019, 134
  • [33] Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia
    Mozessohn, Lee
    Cheung, Matthew C.
    Mittmann, Nicole
    Earle, Craig C.
    Liu, Ning
    Buckstein, Rena
    JCO ONCOLOGY PRACTICE, 2021, 17 (04) : E517 - E525
  • [34] DISTINCTION OF ACUTE MYELOID-LEUKEMIA (AML) WITH LOW BLAST COUNT FROM PEDIATRIC MYELODYSPLASTIC SYNDROME (MDS) IS CLINICALLY IMPORTANT
    CHAN, GCF
    WANG, W
    RAIMONDI, S
    BEHM, F
    KRANCE, R
    HEAD, D
    BLOOD, 1994, 84 (10) : A315 - A315
  • [35] Characteristics and Outcomes of Patients With Acute Myeloid Leukemia and DDX41 Mutation
    Bataller, Alex
    Loghavi, Sanam
    Gerstein, Yoheved
    Bazinet, Alexandre
    Sasaki, Koji
    Chien, Kelly S.
    Hammond, Danielle
    Montalban-Bravo, Guillermo
    Borthakur, Gautam
    Short, Nicholas
    Issa, Ghayas C.
    Kadia, Tapan M.
    Daver, Naval
    Patel, Keyur P.
    Ravandi, Farhad
    Fiskus, Warren
    Mill, Cristopher P.
    Kantarjian, Hagop M.
    Bhalla, Kapil
    Garcia-Manero, Guillermo
    Oran, Betul
    DiNardo, Courtney D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S277 - S277
  • [36] Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia
    Perez, Mauricio
    Barrionuevo, Vanessa
    Arias, Cristina
    Baehring, Joachim M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [37] Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
    R Itzykson
    O Kosmider
    T Cluzeau
    V Mansat-De Mas
    F Dreyfus
    O Beyne-Rauzy
    B Quesnel
    N Vey
    V Gelsi-Boyer
    S Raynaud
    C Preudhomme
    L Adès
    P Fenaux
    M Fontenay
    Leukemia, 2011, 25 : 1147 - 1152
  • [38] Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
    Itzykson, R.
    Kosmider, O.
    Cluzeau, T.
    Mansat-De Mas, V.
    Dreyfus, F.
    Beyne-Rauzy, O.
    Quesnel, B.
    Vey, N.
    Gelsi-Boyer, V.
    Raynaud, S.
    Preudhomme, C.
    Ades, L.
    Fenaux, P.
    Fontenay, M.
    LEUKEMIA, 2011, 25 (07) : 1147 - 1152
  • [39] INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: RETROSPECTIVE ANALYSIS FROM A SINGLE CENTER
    Binotto, G.
    Quinto, A. M.
    De March, E.
    Lessi, F.
    Castelli, M.
    Nabergoj, M.
    Gianesello, I.
    Pavanello, F.
    Branca, A.
    Zambello, R.
    Adami, F.
    Semenzato, G.
    LEUKEMIA RESEARCH, 2015, 39 : S47 - S47
  • [40] Azacitidine in the "real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada
    Mozessohn, Lee
    Cheung, Matthew C.
    Fallahpour, Saber
    Gill, Tripat
    Maloul, Asmaa
    Zhang, Liying
    Lau, Olivia
    Buckstein, Rena
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (06) : 803 - 815
12345